Davide Ruggero, PhD

Title(s)Professor, Urology
SchoolSchool of Medicine
Address1450 3rd Street
San Francisco CA 94158
ORCID ORCID Icon0000-0002-9444-5865 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Rome, La Sapienza, ItalyB.S.1994Biology
    University of Rome, La Sapienza, ItalyPh.D.1998Molecular and Cell Biology
    Collapse Awards and Honors
    1994Enichem Society Fellowship
    1998  - 2000American-Italian Cancer Foundation Fellowship
    2003Outstanding Research Fellow Award at MSKCC
    2005  - 2007V Foundation Scholar Award
    2006  - 2007Pennsylvania Department of Health Merit Award (Commonwealth Universal Research Enhancement Program)
    2008AACR Gertrude B. Elion Cancer Research Award
    2010Leukemia & Lymphoma Society Scholar Award
    2010Phi Beta Psi Sorority National Project Research Award
    2010UCSF Program for Breakthrough Biomedical Research Award
    2010Co-Chair and Organizer, 1st American Association for Cancer Research "Protein Translation and Cancer
    2011Helen Diller Family Endowed Chair of Basic Cancer Research
    2013Co-Organizer, AACR 3rd International Conference on Frontiers in Basic Cancer Research
    2013Chair, 2013 AACR Annual Meeting Major Symposium on "Stress Response Pathways in Cancer"
    2016Co-Chair and Organizer, AACR Special Conference on "Translating the cancer genome: a new frontier in
    2017Chair, Annual AACR Educational Session on "Translation Control in cancer: From Basic Science to Ther
    2017Chair, Annual AACR Educational Session on "Translation Control in cancer: From Basic Science to Ther
    2017Chair, Annual AACR Educational Session on "Translation Control in cancer: From Basic Science to Ther
    2017Chair, Annual AACR Educational Session on "Translation Control in cancer: From Basic Science to Ther
    2017Chair, Annual AACR Educational Session on "Translation Control in cancer: From Basic Science to Ther
    2018Co-Chair, 2018 Cold Spring Harbor Laboratories Meeting on Translational Control
    2019Chair, NCI Special Workshop on Dysregulation of Ribosome Biogenesis & Protein Synthesis in Cancer
    2019NCI Outstanding Investigator Award (R35)
    2019American Cancer Society (ACS) Research Professorship Award
    2020Co-Organizer, ACS “Expanding the Central Dogma to Fight Cancer” Symposium
    2020Co-Organizer, QBI Cancer Cell Symposium

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Mechanisms of regulated translation control in cancer and its therapeutic implications
    NIH R35CA242986Aug 6, 2019 - Jul 31, 2026
    Role: Principal Investigator
    MYCN, mTOR and translation control in medulloblastoma
    NIH R01NS089868Sep 1, 2014 - Jun 30, 2019
    Role: Co-Principal Investigator
    X-linked Dyskeratosis Congenita and ribosomal frameshifting
    NIH R01HL119439Aug 1, 2014 - Apr 30, 2019
    Role: Co-Principal Investigator
    elF4E-Dependent Translation Control in the Oncogenic Stress Response and Cancer
    NIH R01CA184624May 1, 2014 - Apr 30, 2020
    Role: Principal Investigator
    Deciphering the role of the translational oncogenic program in Prostate Cancer
    NIH R01CA154916Sep 1, 2011 - Jun 30, 2022
    Role: Principal Investigator
    Delineating the Mechanisms Responsible for Synthetic Lethality in MYC-induced Tumorigenesis Driven by Control of Protein Synthesis
    NIH R01CA140456Jul 1, 2009 - Apr 30, 2020
    Role: Principal Investigator
    Role of ribosome impairments in X-linked Dyskeratosis Congenita pathogenesis
    NIH R01DK098057Aug 1, 2006 - Jun 30, 2017
    Role: Principal Investigator
    Role of rRNA Modifications in Dyskeratosis Congenita and Translation Control
    NIH R01HL085572Aug 1, 2006 - Jun 30, 2011
    Role: Principal Investigator
    Bio-Organic Biomedical Mass Spectrometry Resource
    NIH P41RR001614Mar 1, 1982 - May 31, 2015
    Role: Co-Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A tRF nucleator for Nucleolin in cancer metastasis. Mol Cell. 2022 07 21; 82(14):2536-2538. Xu Y, Ruggero D. PMID: 35868253.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. The promises and pitfalls of specialized ribosomes. Mol Cell. 2022 06 16; 82(12):2179-2184. Barna M, Karbstein K, Tollervey D, Ruggero D, Brar G, Greer EL, Dinman JD. PMID: 35714581.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    3. Localization of a TORC1-eIF4F translation complex during CD8+ T cell activation drives divergent cell fate. Mol Cell. 2022 07 07; 82(13):2401-2414.e9. Liedmann S, Liu X, Guy CS, Crawford JC, Rodriguez DA, Kuzuoglu-Öztürk D, Guo A, Verbist KC, Temirov J, Chen MJ, Ruggero D, Zhang H, Thomas PG, Green DR. PMID: 35597236; PMCID: PMC9271638.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    4. Protein synthesis control in cancer: selectivity and therapeutic targeting. EMBO J. 2022 04 19; 41(8):e109823. Kovalski JR, Kuzuoglu-Ozturk D, Ruggero D. PMID: 35315941; PMCID: PMC9016353.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    5. ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance. Cell. 2021 09 30; 184(20):5215-5229.e17. Xu Y, Huangyang P, Wang Y, Xue L, Devericks E, Nguyen HG, Yu X, Oses-Prieto JA, Burlingame AL, Miglani S, Goodarzi H, Ruggero D. PMID: 34559986; PMCID: PMC8547373.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    6. A p53-dependent translational program directs tissue-selective phenotypes in a model of ribosomopathies. Dev Cell. 2021 07 26; 56(14):2089-2102.e11. Tiu GC, Kerr CH, Forester CM, Krishnarao PS, Rosenblatt HD, Raj N, Lantz TC, Zhulyn O, Bowen ME, Shokat L, Attardi LD, Ruggero D, Barna M. PMID: 34242585; PMCID: PMC8319123.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    7. Releasing the brake on protein synthesis in hematopoietic stem cells. Cell Stem Cell. 2021 07 01; 28(7):1183-1185. Forester CM, Ruggero D. PMID: 34214436.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    8. Revealing molecular pathways for cancer cell fitness through a genetic screen of the cancer translatome. Cell Rep. 2021 06 29; 35(13):109321. Kuzuoglu-Ozturk D, Hu Z, Rama M, Devericks E, Weiss J, Chiang GG, Worland ST, Brenner SE, Goodarzi H, Gilbert LA, Ruggero D. PMID: 34192540; PMCID: PMC8323864.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    9. Reduced eIF4E function impairs B-cell leukemia without altering normal B-lymphocyte function. iScience. 2021 Jul 23; 24(7):102748. Chiu H, Buono R, Jackson LV, Herzog LO, Mallya S, Conn CS, Ruggero D, Fruman DA. PMID: 34278258; PMCID: PMC8261676.
      View in: PubMed   Mentions: 2  
    10. OMIC-03. TRANSLATIONAL CONTROL IN MYC AND MYCN MEDULLOBLASTOMA. Neuro-Oncology. 2021 Jun 1; 23(Suppl 1):i37-i37. Schmidt SC, Navickas NA, Zindy ZF, Farmer FD, Ruggero RD, Goodarzi GH, Roussel RM, Schwer SB, Weiss WW. .
      View in: Publisher Site   Mentions:
    11. The major cap-binding protein eIF4E regulates lipid homeostasis and diet-induced obesity. Nat Metab. 2021 02; 3(2):244-257. Conn CS, Yang H, Tom HJ, Ikeda K, Oses-Prieto JA, Vu H, Oguri Y, Nair S, Gill RM, Kajimura S, DeBerardinis RJ, Burlingame AL, Ruggero D. PMID: 33619378.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    12. Examining Myc-Dependent Translation Changes in Cellular Homeostasis and Cancer. Methods Mol Biol. 2021; 2318:255-266. Kovalski JR, Xu Y, Ruggero D. PMID: 34019295.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    13. Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies. J Nucl Med. 2021 07 01; 62(7):949-955. Zhao N, Huang Y, Wang YH, Muir RK, Chen YC, Wei J, Hooshdaran N, Viswanath P, Seo Y, Ruggero D, Renslo AR, Evans MJ. PMID: 33246980; PMCID: PMC8882888.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    14. Abstract IA17: Strategies to target the mTORC1/eIF4F axis in B-cell leukemia and lymphoma. Molecular Cancer Research. 2020 Oct 1; 18(10_Supplement):ia17-ia17. Herzog HL, Lee LB, Vo VT, Chiu CH, Mallya MS, Fung FA, Singh SM, Aggen AJ, Tibrewal TN, Smith SJ, Wildes WD, Ronai RZ, Ruggero RD, Fruman FD. .
      View in: Publisher Site   Mentions:
    15. An Analysis of Isoclonal Antibody Formats Suggests a Role for Measuring PD-L1 with Low Molecular Weight PET Radiotracers. Mol Imaging Biol. 2020 12; 22(6):1553-1561. Wei J, Wang YH, Lee CY, Truillet C, Oh DY, Xu Y, Ruggero D, Flavell RR, VanBrocklin HF, Seo Y, Craik CS, Fong L, Wang CI, Evans MJ. PMID: 32813112; PMCID: PMC7669684.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    16. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020 07; 583(7816):459-468. Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O'Meara MJ, Rezelj VV, Guo JZ, Swaney DL, Tummino TA, Hüttenhain R, Kaake RM, Richards AL, Tutuncuoglu B, Foussard H, Batra J, Haas K, Modak M, Kim M, Haas P, Polacco BJ, Braberg H, Fabius JM, Eckhardt M, Soucheray M, Bennett MJ, Cakir M, McGregor MJ, Li Q, Meyer B, Roesch F, Vallet T, Mac Kain A, Miorin L, Moreno E, Naing ZZC, Zhou Y, Peng S, Shi Y, Zhang Z, Shen W, Kirby IT, Melnyk JE, Chorba JS, Lou K, Dai SA, Barrio-Hernandez I, Memon D, Hernandez-Armenta C, Lyu J, Mathy CJP, Perica T, Pilla KB, Ganesan SJ, Saltzberg DJ, Rakesh R, Liu X, Rosenthal SB, Calviello L, Venkataramanan S, Liboy-Lugo J, Lin Y, Huang XP, Liu Y, Wankowicz SA, Bohn M, Safari M, Ugur FS, Koh C, Savar NS, Tran QD, Shengjuler D, Fletcher SJ, O'Neal MC, Cai Y, Chang JCJ, Broadhurst DJ, Klippsten S, Sharp PP, Wenzell NA, Kuzuoglu-Ozturk D, Wang HY, Trenker R, Young JM, Cavero DA, Hiatt J, Roth TL, Rathore U, Subramanian A, Noack J, Hubert M, Stroud RM, Frankel AD, Rosenberg OS, Verba KA, Agard DA, Ott M, Emerman M, Jura N, von Zastrow M, Verdin E, Ashworth A, Schwartz O, d'Enfert C, Mukherjee S, Jacobson M, Malik HS, Fujimori DG, Ideker T, Craik CS, Floor SN, Fraser JS, Gross JD, Sali A, Roth BL, Ruggero D, Taunton J, Kortemme T, Beltrao P, Vignuzzi M, García-Sastre A, Shokat KM, Shoichet BK, Krogan NJ. PMID: 32353859; PMCID: PMC7431030.
      View in: PubMed   Mentions: 1575     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    17. A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing. bioRxiv. 2020 Mar 22. Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, O'Meara MJ, Guo JZ, Swaney DL, Tummino TA, Hüttenhain R, Kaake RM, Richards AL, Tutuncuoglu B, Foussard H, Batra J, Haas K, Modak M, Kim M, Haas P, Polacco BJ, Braberg H, Fabius JM, Eckhardt M, Soucheray M, Bennett MJ, Cakir M, McGregor MJ, Li Q, Naing ZZC, Zhou Y, Peng S, Kirby IT, Melnyk JE, Chorba JS, Lou K, Dai SA, Shen W, Shi Y, Zhang Z, Barrio-Hernandez I, Memon D, Hernandez-Armenta C, Mathy CJP, Perica T, Pilla KB, Ganesan SJ, Saltzberg DJ, Ramachandran R, Liu X, Rosenthal SB, Calviello L, Venkataramanan S, Lin Y, Wankowicz SA, Bohn M, Trenker R, Young JM, Cavero D, Hiatt J, Roth T, Rathore U, Subramanian A, Noack J, Hubert M, Roesch F, Vallet T, Meyer B, White KM, Miorin L, Agard D, Emerman M, Ruggero D, García-Sastre A, Jura N, von Zastrow M, Taunton J, Schwartz O, Vignuzzi M, d'Enfert C, Mukherjee S, Jacobson M, Malik HS, Fujimori DG, Ideker T, Craik CS, Floor S, Fraser JS, Gross J, Sali A, Kortemme T, Beltrao P, Shokat K, Shoichet BK, Krogan NJ. PMID: 32511329; PMCID: PMC7239059.
      View in: PubMed   Mentions: 25  
    18. The Role of Translation Control in Tumorigenesis and Its Therapeutic Implications. Annual Review of Cancer Biology. 2020 Mar 4; 4(1):1-21. Xu XY, Ruggero RD. .
      View in: Publisher Site   Mentions:
    19. Profiling the Surfaceome Identifies Therapeutic Targets for Cells with Hyperactive mTORC1 Signaling. Mol Cell Proteomics. 2020 02; 19(2):294-307. Wei J, Leung K, Truillet C, Ruggero D, Wells JA, Evans MJ. PMID: 31792071; PMCID: PMC7000124.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    20. Regulation of eIF4E Guides a Unique Translational Program to Steer Erythroid Maturation. Blood. 2019 Nov 13; 134(Supplement_1):156-156. Forester FC, Woo-Byeon WG, Oses-Prieto OJ, Burlingame BA, Barna BM, Ruggero RD. .
      View in: Publisher Site   Mentions:
    21. A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS. Elife. 2019 09 03; 8. McMahon M, Contreras A, Holm M, Uechi T, Forester CM, Pang X, Jackson C, Calvert ME, Chen B, Quigley DA, Luk JM, Kelley RK, Gordan JD, Gill RM, Blanchard SC, Ruggero D. PMID: 31478838; PMCID: PMC6776443.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    22. Author Correction: ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression. Nat Cell Biol. 2019 Aug; 21(8):1052. Tameire F, Verginadis II, Leli NM, Polte C, Conn CS, Ojha R, Salinas CS, Chinga F, Monroy AM, Fu W, Wang P, Kossenkov A, Ye J, Amaravadi RK, Ignatova Z, Fuchs SY, Diehl JA, Ruggero D, Koumenis C. PMID: 31316187.
      View in: PubMed   Mentions: 3     Fields:    
    23. Nuclear TARBP2 Drives Oncogenic Dysregulation of RNA Splicing and Decay. Mol Cell. 2019 09 05; 75(5):967-981.e9. Fish L, Navickas A, Culbertson B, Xu Y, Nguyen HCB, Zhang S, Hochman M, Okimoto R, Dill BD, Molina H, Najafabadi HS, Alarcón C, Ruggero D, Goodarzi H. PMID: 31300274; PMCID: PMC6731133.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    24. Translational Control in Cancer. Cold Spring Harb Perspect Biol. 2019 07 01; 11(7). Robichaud N, Sonenberg N, Ruggero D, Schneider RJ. PMID: 29959193; PMCID: PMC6601465.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansAnimalsCells
    25. ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression. Nat Cell Biol. 2019 07; 21(7):889-899. Tameire F, Verginadis II, Leli NM, Polte C, Conn CS, Ojha R, Salas Salinas C, Chinga F, Monroy AM, Fu W, Wang P, Kossenkov A, Ye J, Amaravadi RK, Ignatova Z, Fuchs SY, Diehl JA, Ruggero D, Koumenis C. PMID: 31263264; PMCID: PMC6608727.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansAnimalsCells
    26. Measuring Dynamic Changes in the Labile Iron Pool in Vivo with a Reactivity-Based Probe for Positron Emission Tomography. ACS Cent Sci. 2019 Apr 24; 5(4):727-736. Muir RK, Zhao N, Wei J, Wang YH, Moroz A, Huang Y, Chen YC, Sriram R, Kurhanewicz J, Ruggero D, Renslo AR, Evans MJ. PMID: 31041393; PMCID: PMC6487455.
      View in: PubMed   Mentions: 12  
    27. A Legionella pneumophila Kinase Phosphorylates the Hsp70 Chaperone Family to Inhibit Eukaryotic Protein Synthesis. Cell Host Microbe. 2019 03 13; 25(3):454-462.e6. Moss SM, Taylor IR, Ruggero D, Gestwicki JE, Shokat KM, Mukherjee S. PMID: 30827827; PMCID: PMC6529236.
      View in: PubMed   Mentions: 15     Fields:    Translation:Cells
    28. Translation control of the immune checkpoint in cancer and its therapeutic targeting. Nat Med. 2019 02; 25(2):301-311. Xu Y, Poggio M, Jin HY, Shi Z, Forester CM, Wang Y, Stumpf CR, Xue L, Devericks E, So L, Nguyen HG, Griselin A, Gordan JD, Umetsu SE, Reich SH, Worland ST, Asthana S, Barna M, Webster KR, Cunningham JT, Ruggero D. PMID: 30643286; PMCID: PMC6613562.
      View in: PubMed   Mentions: 71     Fields:    Translation:AnimalsCells
    29. The mTORC1/4E-BP/eIF4E Axis Promotes Antibody Class Switching in B Lymphocytes. J Immunol. 2019 01 15; 202(2):579-590. Chiu H, Jackson LV, Oh KI, Mai A, Ronai ZA, Ruggero D, Fruman DA. PMID: 30530594; PMCID: PMC6324996.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    30. A Translation Tuning HuDdle for Neurons. Mol Cell. 2018 07 19; 71(2):195-196. McMahon M, Ruggero D. PMID: 30028999.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    31. A wobbly road to drug resistance in melanoma: tRNA-modifying enzymes in translation reprogramming. EMBO J. 2018 08 01; 37(15). McMahon M, Ruggero D. PMID: 29967029; PMCID: PMC6068441.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    32. Development of a stress response therapy targeting aggressive prostate cancer. Sci Transl Med. 2018 05 02; 10(439). Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC, Cunningham JT, Truillet C, Tameire F, Evans MJ, Evans CP, Yang JC, Hann B, Koumenis C, Walter P, Carroll PR, Ruggero D. PMID: 29720449; PMCID: PMC6045425.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimalsCells
    33. Revealing nascent proteomics in signaling pathways and cell differentiation. Proc Natl Acad Sci U S A. 2018 03 06; 115(10):2353-2358. Forester CM, Zhao Q, Phillips NJ, Urisman A, Chalkley RJ, Oses-Prieto JA, Zhang L, Ruggero D, Burlingame AL. PMID: 29467287; PMCID: PMC5877968.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    34. Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase. Cancer Cell. 2018 01 08; 33(1):91-107.e6. Gwinn DM, Lee AG, Briones-Martin-Del-Campo M, Conn CS, Simpson DR, Scott AI, Le A, Cowan TM, Ruggero D, Sweet-Cordero EA. PMID: 29316436; PMCID: PMC5761662.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansAnimalsCells
    35. A PERK-miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival. Nat Cell Biol. 2018 01; 20(1):104-115. Bu Y, Yoshida A, Chitnis N, Altman BJ, Tameire F, Oran A, Gennaro V, Armeson KE, McMahon SB, Wertheim GB, Dang CV, Ruggero D, Koumenis C, Fuchs SY, Diehl JA. PMID: 29230015; PMCID: PMC5741512.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimalsCells
    36. CSIG-42. UNDERSTANDING THE ROLE OF TRANSLATIONAL CONTROL IN MYCN-DRIVEN MEDULLOBLASTOMA. Neuro-Oncology. 2017 Nov 6; 19(suppl_6):vi58-vi58. Aksoy AO, Fan FQ, Shokat SK, Ruggero RD, Weiss WW. .
      View in: Publisher Site   Mentions:
    37. New frontiers in translational control of the cancer genome. Nat Rev Cancer. 2017 04 24; 17(5):332. Truitt ML, Ruggero D. PMID: 28436470.
      View in: PubMed   Mentions: 25     Fields:    
    38. Editorial overview: Cell regulation: 1000 Flavors including chocolate and chili peppers. Curr Opin Cell Biol. 2017 04; 45:iv-vi. Ruggero D, Shaw RJ. PMID: 28641761.
      View in: PubMed   Mentions:    Fields:    
    39. Noninvasive Measurement of mTORC1 Signaling with 89Zr-Transferrin. Clin Cancer Res. 2017 Jun 15; 23(12):3045-3052. Truillet C, Cunningham JT, Parker MFL, Huynh LT, Conn CS, Ruggero D, Lewis JS, Evans MJ. PMID: 28007777; PMCID: PMC5474159.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    40. The 4E-BP-eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes. Sci Signal. 2016 05 31; 9(430):ra57. So L, Lee J, Palafox M, Mallya S, Woxland CG, Arguello M, Truitt ML, Sonenberg N, Ruggero D, Fruman DA. PMID: 27245614; PMCID: PMC4924540.
      View in: PubMed   Mentions: 29     Fields:    Translation:AnimalsCells
    41. New frontiers in translational control of the cancer genome. Nat Rev Cancer. 2016 04 26; 16(5):288-304. Truitt ML, Ruggero D. PMID: 27112207; PMCID: PMC5491099.
      View in: PubMed   Mentions: 141     Fields:    Translation:HumansCells
    42. Automated High-Throughput Quantification Reveals Morphological Heterogeneity in Mammalian Cell Populations. Biophysical Journal. 2016 Feb 1; 110(3):317a. Chang CA, Chen CS, Truitt TM, Ruggero RD, Marshall MW. .
      View in: Publisher Site   Mentions:
    43. A Tailor-Made Protein Synthesis Program Drives Erythroid Development and Disease. Blood. 2015 Dec 3; 126(23):3581-3581. Forester FC, Shi SZ, Barna BM, Ruggero RD. .
      View in: Publisher Site   Mentions:
    44. Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors. Sci Signal. 2015 Nov 17; 8(403):ra116. Hsieh AC, Nguyen HG, Wen L, Edlind MP, Carroll PR, Kim W, Ruggero D. PMID: 26577921; PMCID: PMC4739654.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    45. Differential Requirements for eIF4E Dose in Normal Development and Cancer. Cell. 2015 Jul 02; 162(1):59-71. Truitt ML, Conn CS, Shi Z, Pang X, Tokuyasu T, Coady AM, Seo Y, Barna M, Ruggero D. PMID: 26095252; PMCID: PMC4491046.
      View in: PubMed   Mentions: 157     Fields:    Translation:AnimalsCells
    46. Enhanced MET Translation and Signaling Sustains K-Ras-Driven Proliferation under Anchorage-Independent Growth Conditions. Cancer Res. 2015 Jul 15; 75(14):2851-62. Fujita-Sato S, Galeas J, Truitt M, Pitt C, Urisman A, Bandyopadhyay S, Ruggero D, McCormick F. PMID: 25977330; PMCID: PMC4506276.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    47. YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence. Oncotarget. 2015 Apr 10; 6(10):7470-80. Sheridan CM, Grogan TR, Nguyen HG, Galet C, Rettig MB, Hsieh AC, Ruggero D. PMID: 25797255; PMCID: PMC4480693.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    48. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development. Cancer Res. 2015 Jan 15; 75(2):250-63. Pelletier J, Graff J, Ruggero D, Sonenberg N. PMID: 25593033; PMCID: PMC4299928.
      View in: PubMed   Mentions: 153     Fields:    Translation:HumansAnimals
    49. 38 Molecular Basis of Prostate Cancer. . 2015 Jan 1; (CA Cancer J Clin 62 2012):549-560.e1. Li LL, Hsieh HA, Ruggero RD, Greene GK, Carroll CP. .
      View in: Publisher Site   Mentions:
    50. Early Hematopoietic Progenitors of Dkc1 Hypomorphic Mutant Mice Display Decreased Proliferation Rate and an Impaired Control of Serine/Arginine-Rich Splicing Factor 4 (Srsf4) Translation. Blood. 2014 Dec 6; 124(21):2937-2937. Lucena-Araujo LA, Santana-Lemos SB, Thome TC, Ferreira FG, Ruggero RD, Faça FV, Rego RE. .
      View in: Publisher Site   Mentions:
    51. Small RNAs with big implications: new insights into H/ACA snoRNA function and their role in human disease. Wiley Interdiscip Rev RNA. 2015 Mar-Apr; 6(2):173-89. McMahon M, Contreras A, Ruggero D. PMID: 25363811; PMCID: PMC4390053.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    52. Marrow failure: a window into ribosome biology. Blood. 2014 Oct 30; 124(18):2784-92. Ruggero D, Shimamura A. PMID: 25237201; PMCID: PMC4215310.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansAnimalsCells
    53. Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer. Cell. 2014 Jul 1; 158(3):689. Cunningham CJ, Moreno MM, Lodi LA, Ronen RS, Ruggero RD. .
      View in: Publisher Site   Mentions:
    54. Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer. Cell. 2014 May 22; 157(5):1088-103. Cunningham JT, Moreno MV, Lodi A, Ronen SM, Ruggero D. PMID: 24855946; PMCID: PMC4140650.
      View in: PubMed   Mentions: 106     Fields:    Translation:HumansAnimalsCells
    55. Tailor made protein synthesis for HSCs. Cell Stem Cell. 2014 Apr 03; 14(4):423-4. Barna M, Ruggero D. PMID: 24702992; PMCID: PMC4071939.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    56. mTOR and Regulation of Translation. Translation and Its Regulation in Cancer Biology and Medicine. 2014 Jan 1; 307-343. Tsukumo TY, Laplante LM, Parsyan PA, Ruggero RD, Fonseca FB. .
      View in: Publisher Site   Mentions:
    57. Parallel measurement of dynamic changes in translation rates in single cells. Nat Methods. 2014 Jan; 11(1):86-93. Han K, Jaimovich A, Dey G, Ruggero D, Meyuhas O, Sonenberg N, Meyer T. PMID: 24213167; PMCID: PMC4039304.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    58. The translational landscape of the mammalian cell cycle. Mol Cell. 2013 Nov 21; 52(4):574-82. Stumpf CR, Moreno MV, Olshen AB, Taylor BS, Ruggero D. PMID: 24120665; PMCID: PMC3959127.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansAnimalsCells
    59. New connections between old pathways: PDK1 signaling promotes cellular transformation through PLK1-dependent MYC stabilization. Cancer Discov. 2013 Oct; 3(10):1099-102. Cunningham JT, Ruggero D. PMID: 24124229; PMCID: PMC3857155.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    60. Assessing gene-level translational control from ribosome profiling. Bioinformatics. 2013 Dec 01; 29(23):2995-3002. Olshen AB, Hsieh AC, Stumpf CR, Olshen RA, Ruggero D, Taylor BS. PMID: 24048356; PMCID: PMC3834798.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimalsCells
    61. Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers. Proc Natl Acad Sci U S A. 2013 Jul 16; 110(29):11988-93. Pourdehnad M, Truitt ML, Siddiqi IN, Ducker GS, Shokat KM, Ruggero D. PMID: 23803853; PMCID: PMC3718086.
      View in: PubMed   Mentions: 121     Fields:    Translation:HumansAnimalsCells
    62. H/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation. Cell Rep. 2013 May 30; 3(5):1493-502. Bellodi C, McMahon M, Contreras A, Juliano D, Kopmar N, Nakamura T, Maltby D, Burlingame A, Savage SA, Shimamura A, Ruggero D. PMID: 23707062; PMCID: PMC3857015.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    63. Common variable immunodeficiency as the initial presentation of dyskeratosis congenita. J Allergy Clin Immunol. 2013 Jul; 132(1):223-6. Allenspach EJ, Bellodi C, Jeong D, Kopmar N, Nakamura T, Ochs HD, Ruggero D, Skoda-Smith S, Shimamura A, Torgerson TR. PMID: 23403051; PMCID: PMC4560355.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    64. Translational control in cancer etiology. Cold Spring Harb Perspect Biol. 2013 Feb 01; 5(2). Ruggero D. PMID: 22767671; PMCID: PMC3552512.
      View in: PubMed   Mentions: 147     Fields:    Translation:HumansCells
    65. Investigating Myc-dependent translational regulation in normal and cancer cells. Methods Mol Biol. 2013; 1012:201-12. Cunningham JT, Pourdehnad M, Stumpf CR, Ruggero D. PMID: 24006066; PMCID: PMC4390065.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    66. Exaggerated translation causes synaptic and behavioural aberrations associated with autism. Nature. 2013 Jan 17; 493(7432):411-5. Santini E, Huynh TN, MacAskill AF, Carter AG, Pierre P, Ruggero D, Kaphzan H, Klann E. PMID: 23263185; PMCID: PMC3548017.
      View in: PubMed   Mentions: 183     Fields:    Translation:AnimalsCells
    67. Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature. 2013 Jan 17; 493(7432):371-7. Gkogkas CG, Khoutorsky A, Ran I, Rampakakis E, Nevarko T, Weatherill DB, Vasuta C, Yee S, Truitt M, Dallaire P, Major F, Lasko P, Ruggero D, Nader K, Lacaille JC, Sonenberg N. PMID: 23172145; PMCID: PMC4133997.
      View in: PubMed   Mentions: 244     Fields:    Translation:AnimalsCells
    68. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. J Clin Invest. 2012 Dec; 122(12):4621-34. Hart LS, Cunningham JT, Datta T, Dey S, Tameire F, Lehman SL, Qiu B, Zhang H, Cerniglia G, Bi M, Li Y, Gao Y, Liu H, Li C, Maity A, Thomas-Tikhonenko A, Perl AE, Koong A, Fuchs SY, Diehl JA, Mills IG, Ruggero D, Koumenis C. PMID: 23143306; PMCID: PMC3533536.
      View in: PubMed   Mentions: 177     Fields:    Translation:HumansAnimalsCells
    69. Translational Control in Cancer Etiology. Cold Spring Harbor Perspectives in Biology. 2012 Nov 1; 4(11):a015891. Ruggero RD. .
      View in: Publisher Site   Mentions:
    70. IRE1α cleaves select microRNAs during ER stress to derepress translation of proapoptotic Caspase-2. Science. 2012 Nov 09; 338(6108):818-22. Upton JP, Wang L, Han D, Wang ES, Huskey NE, Lim L, Truitt M, McManus MT, Ruggero D, Goga A, Papa FR, Oakes SA. PMID: 23042294; PMCID: PMC3742121.
      View in: PubMed   Mentions: 283     Fields:    Translation:HumansAnimalsCells
    71. Revisiting the nucleolus: from marker to dynamic integrator of cancer signaling. Sci Signal. 2012 Sep 11; 5(241):pe38. Ruggero D. PMID: 22969157; PMCID: PMC4390046.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansAnimalsCells
    72. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 2012 Feb 22; 485(7396):55-61. Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, Shi EY, Stumpf CR, Christensen C, Bonham MJ, Wang S, Ren P, Martin M, Jessen K, Feldman ME, Weissman JS, Shokat KM, Rommel C, Ruggero D. PMID: 22367541; PMCID: PMC3663483.
      View in: PubMed   Mentions: 632     Fields:    Translation:HumansAnimalsCells
    73. The “Fifth” RNA Nucleotide: A Role for Ribosomal RNA Pseudouridylation in Control of Gene Expression at the Translational Level. Biophysical approaches to translational control of gene expression. 2012 Jan 1; 253-288. McMahon MM, Bellodi BC, Ruggero RD. .
      View in: Publisher Site   Mentions:
    74. rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells. Mol Cell. 2011 Nov 18; 44(4):660-6. Jack K, Bellodi C, Landry DM, Niederer RO, Meskauskas A, Musalgaonkar S, Kopmar N, Krasnykh O, Dean AM, Thompson SR, Ruggero D, Dinman JD. PMID: 22099312; PMCID: PMC3222873.
      View in: PubMed   Mentions: 146     Fields:    Translation:HumansAnimalsCells
    75. Oncogenic AKTivation of translation as a therapeutic target. Br J Cancer. 2011 Jul 26; 105(3):329-36. Hsieh AC, Truitt ML, Ruggero D. PMID: 21772331; PMCID: PMC3172900.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    76. The cancerous translation apparatus. Curr Opin Genet Dev. 2011 Aug; 21(4):474-83. Stumpf CR, Ruggero D. PMID: 21543223; PMCID: PMC3481834.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimalsCells
    77. Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer. Clin Cancer Res. 2010 Oct 15; 16(20):4914-20. Hsieh AC, Ruggero D. PMID: 20702611; PMCID: PMC7539621.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansAnimals
    78. Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis. Cancer Res. 2010 Jul 15; 70(14):6026-35. Bellodi C, Krasnykh O, Haynes N, Theodoropoulou M, Peng G, Montanaro L, Ruggero D. PMID: 20587522; PMCID: PMC2913864.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansAnimals
    79. Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita. EMBO J. 2010 Jun 02; 29(11):1865-76. Bellodi C, Kopmar N, Ruggero D. PMID: 20453831; PMCID: PMC2885924.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansCells
    80. Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. Cancer Cell. 2010 Mar 16; 17(3):249-61. Hsieh AC, Costa M, Zollo O, Davis C, Feldman ME, Testa JR, Meyuhas O, Shokat KM, Ruggero D. PMID: 20227039; PMCID: PMC2901095.
      View in: PubMed   Mentions: 235     Fields:    Translation:AnimalsCells
    81. The role of Myc-induced protein synthesis in cancer. Cancer Res. 2009 Dec 01; 69(23):8839-43. Ruggero D. PMID: 19934336; PMCID: PMC2880919.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansAnimalsCells
    82. Kaplan et al. reply. Nature. 2009 Sep 1; 461(7262):e5-e5. Kaplan KR, Riba RR, Zacharoulis ZS, Bramley BA, Vincent VL, Costa CC, MacDonald MD, Jin JD, Shido SK, Kerns KS, Zhu ZZ, Hicklin HD, Wu WY, Port PJ, Altorki AN, Port PE, Ruggero RD, Shmelkov SS, Jensen JK, Rafii RS, Lyden LD, Wels WJ. .
      View in: Publisher Site   Mentions:
    83. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol. 2009 Feb 10; 7(2):e38. Feldman ME, Apsel B, Uotila A, Loewith R, Knight ZA, Ruggero D, Shokat KM. PMID: 19209957; PMCID: PMC2637922.
      View in: PubMed   Mentions: 556     Fields:    Translation:AnimalsCells
    84. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature. 2008 Dec 18; 456(7224):971-5. Barna M, Pusic A, Zollo O, Costa M, Kondrashov N, Rego E, Rao PH, Ruggero D. PMID: 19011615; PMCID: PMC2880952.
      View in: PubMed   Mentions: 217     Fields:    Translation:AnimalsCells
    85. 130 INVITED Novel insight into the pathogenesis of dyskeratosis congenita: how defective ribosome activity can cause cancer and disease. European Journal of Cancer Supplements. 2007 Sep 1; 5(4):35-36. Ruggero RD, Yoon YA, Peng PG, Zollo ZO, Adamo AR, Haynes HN, Xu XW, Rego RE. .
      View in: Publisher Site   Mentions:
    86. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science. 2006 May 12; 312(5775):902-6. Yoon A, Peng G, Brandenburger Y, Brandenburg Y, Zollo O, Xu W, Rego E, Ruggero D. PMID: 16690864.
      View in: PubMed   Mentions: 210     Fields:    Translation:HumansAnimalsCells
    87. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha. Oncogene. 2006 Mar 23; 25(13):1974-9. Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, Pandolfi PP. PMID: 16331271.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    88. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005 Dec 08; 438(7069):820-7. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D. PMID: 16341007; PMCID: PMC2945882.
      View in: PubMed   Mentions: 1208     Fields:    Translation:HumansAnimalsCells
    89. The Akt of translational control. Oncogene. 2005 Nov 14; 24(50):7426-34. Ruggero D, Sonenberg N. PMID: 16288289.
      View in: PubMed   Mentions: 88     Fields:    Translation:Cells
    90. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med. 2004 May; 10(5):484-6. Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C, Pandolfi PP. PMID: 15098029.
      View in: PubMed   Mentions: 249     Fields:    Translation:Animals
    91. Does the ribosome translate cancer? Nat Rev Cancer. 2003 Mar; 3(3):179-92. Ruggero D, Pandolfi PP. PMID: 12612653.
      View in: PubMed   Mentions: 409     Fields:    Translation:Cells
    92. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science. 2003 Jan 10; 299(5604):259-62. Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, Rao PH, Cordon-Cardo C, Pandolfi PP. PMID: 12522253.
      View in: PubMed   Mentions: 182     Fields:    Translation:AnimalsCells
    93. Plzf mediates transcriptional repression of HoxD gene expression through chromatin remodeling. Dev Cell. 2002 Oct; 3(4):499-510. Barna M, Merghoub T, Costoya JA, Ruggero D, Branford M, Bergia A, Samori B, Pandolfi PP. PMID: 12408802.
      View in: PubMed   Mentions: 54     Fields:    Translation:AnimalsCells
    94. The puzzling multiple lives of PML and its role in the genesis of cancer. Bioessays. 2000 Sep; 22(9):827-35. Ruggero D, Wang ZG, Pandolfi PP. PMID: 10944585.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    95. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis. J Exp Med. 2000 Feb 21; 191(4):631-40. Zhong S, Salomoni P, Ronchetti S, Guo A, Ruggero D, Pandolfi PP. PMID: 10684855; PMCID: PMC2195846.
      View in: PubMed   Mentions: 46     Fields:    Translation:AnimalsCells
    96. Cis-acting signals controlling translational initiation in the thermophilic archaeon Sulfolobus solfataricus. Mol Microbiol. 1999 Oct; 34(2):377-84. Condò I, Ciammaruconi A, Benelli D, Ruggero D, Londei P. PMID: 10564480.
      View in: PubMed   Mentions: 37     Fields:    Translation:Cells
    97. PML is essential for multiple apoptotic pathways. Nat Genet. 1998 Nov; 20(3):266-72. Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R, Pandolfi PP. PMID: 9806545.
      View in: PubMed   Mentions: 153     Fields:    Translation:AnimalsCells
    98. A novel aminopeptidase associated with the 60 kDa chaperonin in the thermophilic archaeon Sulfolobus solfataricus. Mol Microbiol. 1998 Aug; 29(3):775-85. Condò I, Ruggero D, Reinhardt R, Londei P. PMID: 9723917.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    99. The chaperonin of the archaeon Sulfolobus solfataricus is an RNA-binding protein that participates in ribosomal RNA processing. EMBO J. 1998 Jun 15; 17(12):3471-7. Ruggero D, Ciammaruconi A, Londei P. PMID: 9628882; PMCID: PMC1170683.
      View in: PubMed   Mentions: 12     Fields:    Translation:Cells
    100. Differential antibiotic sensitivity determined by the large ribosomal subunit in thermophilic archaea. J Bacteriol. 1996 Jun; 178(11):3396-8. Ruggero D, Londei P. PMID: 8655531; PMCID: PMC178103.
      View in: PubMed   Mentions: 2     Fields:    Translation:Cells
    101. In vitro translation of archaeal natural mRNAs at high temperature. FEMS Microbiology Letters. 1993 Feb 1; 107(1):89-94. Ruggero RD, Creti CR, Londei LP. .
      View in: Publisher Site   Mentions:
    102. Lithium and granulocytopenia during induction treatment of adult acute lymphoblastic leukemia. Tumori. 1982 Oct 31; 68(5):427-30. Bandini G, Ricci P, Ruggero D, Cantore M, Visani G, Tura S. PMID: 6960590.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    103. Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation. Br Med J (Clin Res Ed). 1981 Mar 14; 282(6267):860-3. Speck B, Gratwohl A, Nissen C, Leibundgut U, Ruggero D, Osterwalder B, Burri HP, Cornu P, Jeannet M. PMID: 6783204; PMCID: PMC1504686.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    104. [Experience with intensive plasma exchange]. Schweiz Med Wochenschr. 1980 Oct 04; 110(40):1449-51. Gratwohl A, Cornu P, Nissen C, Ruggero D, Osterwalder B, Speck B. PMID: 7280593.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    105. Serum lysozyme level in adult acute non-lymphoid leukaemia. Haematologica. 1979 Jun; 64(3):288-95. Bandini G, Ricci P, Baccarani M, Ruggero D, Tura S. PMID: 113297.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    106. Adult acute lymphoblastic leukaemia: study of 32 patients and analysis of prognostic factors. Scand J Haematol. 1979 Feb; 22(2):154-64. Ruggero D, Baccarani M, Gobbi M, Tura S. PMID: 311937.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    107. Sex and prognosis in adult acute lymphoblastic leukaemia. Br Med J. 1978 Dec 09; 2(6152):1646. Baccarani M, Ruggero D, Gobbi M, Tura S. PMID: 281982; PMCID: PMC1608841.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    108. Ph1-positive chronic myeloid leukaemia presenting in blastic crisis: report of 12 cases. Boll Ist Sieroter Milan. 1978 Jul 31; 57(3):383-91. Zaccaria A, Ruggero D, Guolo ML, Guarini A, Frezza R, Baccarani M, Tura S. PMID: 282907.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    109. Therapy of chronic myeloid leukemia (CML): interim report on protocols CML/73 and CML/74. Boll Ist Sieroter Milan. 1978 Jul 31; 57(3):278-88. Baccarani M, Ruggero D, Tura S. PMID: 367386.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    110. Immunotherapy with BCG and leukemic blast cells during complete remission of acute myeloid leukemia. Haematologica. 1977 Oct; 62(5):529-36. Gobbi M, Ruggero D, Baccarani M, Zaccaria A, Tomasini I, Tura S. PMID: 412739.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    111. Nervous system involvement in adult acute myeloid leukaemia: report of five cases. Haematologica. 1977 Jun; 62(3):312-9. Ruggero D, Baccarani M, Zaccaria A, Gobbi M, Tomasini I, Tura S. PMID: 408244.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    112. Immunological study of patients with Hodgkin's disease in long-lasting not-maintained complete remission. Boll Ist Sieroter Milan. 1977 Mar 31; 56(2):144-51. Gobbi M, Fiacchini M, Tomasini I, Ruggero D, Lauria F, Tura S. PMID: 326273.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    113. Acute promyelocytic leukemia: results of therapy and analysis of 13 cases. Acta Haematol. 1977; 58(2):108-19. Ruggero D, Baccarani M, Guarini A, Gugliotta L, Gobbi M, Ricci P, Zaccaria A, Lauria F, Tomasini I, Fiacchini M, Santucci MA, Tura S. PMID: 409019.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    114. [Progress and problems in the treatment of acute myeloid leukemia: analysis of 92 cases]. G Clin Med. 1976 Sep-Oct; 57(9-10):283-97. Ruggero D, Baccarani M, Tomasini I, Gobbi M, Santucci MA, Guarini A, Tura S. PMID: 1072018.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    115. ["Cured" Hodgkin's disease in a retrospective study of 147 cases]. G Clin Med. 1976 Mar-Aug; 57(5-6):167-82. Fiacchini M, Ruggero D, Tomasini I, Sciascia R, Emiliani E, Babini L. PMID: 1010166.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    116. [Antibiotic therapy in the high risk patient (hematologic study)]. G Clin Med. 1976 Mar-Apr; 57(3-4):92-104. Tura S, Ruggero D. PMID: 1001857.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    117. A simultaneous study of bone marrow, spleen, and liver in chronic myeloid leukemia: evidence for differences in cell composition and karyotypes. Ser Haematol. 1975; 8(4):81-112. Baccarani M, Zaccaria A, Santucci AM, Bagnara GP, Ricci P, Gobbi M, Ruggero D, Brunelli MA, Tura S. PMID: 1071286.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    Davide's Networks
    Concepts (503)
    Derived automatically from this person's publications.
    Co-Authors (94)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department